We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

39 hedge funds and large institutions have $255M invested in Foghorn Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

1.55% more ownership

Funds ownership: 63.34% → 64.88% (+1.5%)

13% less funds holding

Funds holding: 45 → 39 (-6)

17% less capital invested

Capital invested by funds: $307M → $255M (-$51.6M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.68%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
3
Increased
20
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$7.21M
2
Morgan Stanley
Morgan Stanley
New York
+$6.39M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.01M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$993K
5
State Street
State Street
Massachusetts
+$875K

Top Sellers

1
CAM
Cormorant Asset Management
Massachusetts
-$13.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.44M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$1.29M
4
OCA
Octagon Capital Advisors
New York
-$911K
5
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$404K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$135M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$27.1M -$355K -32,600 -1%
AG
3
Artal Group
Luxembourg
$18.4M – – –
EC
4
Euclidean Capital
New York
$13.5M – – –
BlackRock
5
BlackRock
New York
$11.7M +$7.21M +661,735 +153%
Morgan Stanley
6
Morgan Stanley
New York
$10.5M +$6.39M +586,487 +149%
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.3M +$3.01M +276,444 +68%
MIM
8
Monashee Investment Management
Massachusetts
$5.66M – – –
AI
9
Alphabet Inc
California
$5.34M – – –
BC
10
Birchview Capital
Vermont
$3.35M – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.54M +$993K +91,104 +62%
CC
12
Casdin Capital
New York
$2.31M – – –
Millennium Management
13
Millennium Management
New York
$2.09M +$367K +33,644 +21%
State Street
14
State Street
Massachusetts
$2.02M +$875K +80,300 +74%
Deutsche Bank
15
Deutsche Bank
Germany
$2.02M -$368K -33,805 -15%
Northern Trust
16
Northern Trust
Illinois
$1.74M +$857K +78,604 +93%
SCM
17
Suvretta Capital Management
New York
$896K – – –
Charles Schwab
18
Charles Schwab
California
$762K +$259K +23,758 +50%
N
19
Nuveen
North Carolina
$602K +$486K +44,603 +378%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$549K +$348K +31,979 +165%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$288K +$175K +16,099 +148%
JP Morgan Chase
22
JP Morgan Chase
New York
$280K +$67.8K +6,224 +31%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$219K +$22.3K +2,050 +11%
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$179K +$138K +12,658 +309%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$167K +$171K +15,659 New
1
2

FHTX Hedge Fund Activity: Q2 2021 in Review

39 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q2 2021, worth a combined $255M — down 17% from $307M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of FHTX and 3 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 20 added.

The largest buyer was BlackRock, adding an estimated $7.21M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $13.2M sold.

  • 39 institutional investors held Foghorn Therapeutics (FHTX) as of Q2 2021, down from 45 in Q1 2021.
  • Funds reported $255M of Foghorn Therapeutics stock for Q2 2021, down 17% quarter-over-quarter.
  • 3 funds opened new Foghorn Therapeutics positions in Q2 2021 and 9 closed out, a net change of -6 holders.
  • The largest Foghorn Therapeutics buyer in Q2 2021 was BlackRock, an estimated $7.21M added.
  • The largest Foghorn Therapeutics seller in Q2 2021 was Cormorant Asset Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q2 2021.